Literature DB >> 26667621

S3-Guideline non-traumatic adult femoral head necrosis.

A Roth1, J Beckmann2, K Bohndorf3,4, A Fischer5, C Heiß6, W Kenn7, M Jäger8, U Maus9, U Nöth10, K M Peters11, C Rader12, S Reppenhagen13, U Smolenski14, M Tingart15, I Kopp16, I Sirotin17, S J Breusch18.   

Abstract

INTRODUCTION: The treatment of adult non-traumatic avascular necrosis of the femoral head (AVN; N-ANFH) within an estimated incidence of 5000-7000 cases per annum in Germany remains a challenge. Risk factors include steroids, alcohol abuse, chemotherapy and immunosuppressive medication, but a genetic predisposition has been suggested. Early diagnosis of this often bilateral disease process is essential for successful conservative or joint preserving surgical management. In this review, we present the update German consensus S3 guideline "diagnosis and management for N-ANFH" as a concise summary.
MATERIALS AND METHODS: This systematic review is based on the published literature from January 1, 1970 to April 31, 2013 (German and English language). Inclusion criteria were systematic reviews, meta-analyses and relevant peer review publications. We identified a total of 3715 related publications, of which 422 were suitable according to the SIGN criteria, but only 159 fulfilled our inclusion criteria. RESULTS AND
CONCLUSIONS: Clinical suspicion of N-ANFH mandates radiographic evaluation. If radiographs are normal MRI scans are recommended, which should be evaluated according to the ARCO-classification. Differential diagnoses include transient osteoporosis, bone bruise, insufficiency fracture and destructive arthropathy. Untreated, subchondral fractures commonly occur within 2 years, during which the risk for contralateral involvement is high-thereafter unlikely. Conservative management with Ilomedin and Alendronat can be tried, but other pharmacological or physical treatments are inappropriate. No specific joint preserving procedure can be recommended, but core decompression should be considered in early stages if necrosis is <30 %. In ARCO stages IIIc or IV total hip arthroplasty (THA) should be contemplated, which offers similar outcome compared to osteoarthritis. Young age is the main risk factor for higher revision rates after THA for N-ANFH.

Entities:  

Keywords:  AVN; Atraumatic avascular necrosis; Bisphosphonate; Bone grafting; Bone transplant; Core decompression; Diagnosis; Ilomedin; Total hip arthroplasty; Total hip replacement

Mesh:

Substances:

Year:  2015        PMID: 26667621     DOI: 10.1007/s00402-015-2375-7

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  16 in total

Review 1.  [Update of the German S3 guideline on atraumatic femoral head necrosis in adults].

Authors:  Andreas Roth; Johannes Beckmann; Klaus Bohndorf; Christian Heiß; Marcus Jäger; Stefan Landgraeber; Uwe Maus; Ulrich Nöth; Klaus M Peters; Christof Rader; Stephan Reppenhagen; Ulrich Smolenski; Ina Kopp; Markus Tingart
Journal:  Orthopade       Date:  2018-09       Impact factor: 1.087

Review 2.  [Total hip replacement in avascular femoral head necrosis].

Authors:  M Betsch; M Tingart; A Driessen; V Quack; B Rath
Journal:  Orthopade       Date:  2018-09       Impact factor: 1.087

3.  Evaluation of bone viability in patients after girdlestone arthroplasty: comparison of bone SPECT/CT and MRI.

Authors:  G Diederichs; P Hoppe; F Collettini; G Wassilew; B Hamm; W Brenner; M R Makowski
Journal:  Skeletal Radiol       Date:  2017-06-16       Impact factor: 2.199

4.  Whole-joint magnetic resonance imaging to assess osteonecrosis in pediatric patients with acute lymphoblastic lymphoma.

Authors:  Hiroto Inaba; Olga Varechtchouk; Michael D Neel; Matthew J Ehrhardt; Monika L Metzger; Seth E Karol; Kirsten K Ness; Raul C Ribeiro; Ching-Hon Pui; Mary V Relling; John T Sandlund; Sue C Kaste
Journal:  Pediatr Blood Cancer       Date:  2020-05-30       Impact factor: 3.167

5.  Association of ABCB1 and CYP450 Gene Polymorphisms and their DNA Methylation Status with Steroid-Induced Osteonecrosis of the Femoral Head in the Chinese Population.

Authors:  Ronglan Huang; Qinghao Zhan; Wenbin Hu; Renmin Yang; Nan Cheng; Yongsheng Han; Xiuyu Yue
Journal:  Genet Test Mol Biomarkers       Date:  2020-11-27

6.  Nontraumatic avascular necrosis of the femoral head : Arthroscopic and navigation-supported core decompression.

Authors:  Jan Theopold; Sarah Armonies; Philipp Pieroh; Pierre Hepp; Andreas Roth
Journal:  Oper Orthop Traumatol       Date:  2019-11-28       Impact factor: 1.154

7.  The efficacy of acupuncture and moxibustion for early and middle-stage osteonecrosis of the femeral head: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Hongguang Jin; Linhui Li; Wen Yu; Yong Fu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 8.  Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update.

Authors:  Michael A Mont; Hytham S Salem; Nicolas S Piuzzi; Stuart B Goodman; Lynne C Jones
Journal:  J Bone Joint Surg Am       Date:  2020-06-17       Impact factor: 6.558

9.  Cortisol inhibits mTOR signaling in avascular necrosis of the femoral head.

Authors:  Yun Liao; Rui Su; Ping Zhang; Bo Yuan; Ling Li
Journal:  J Orthop Surg Res       Date:  2017-10-18       Impact factor: 2.359

10.  Multiple drilling is not effective in reducing the rate of conversion to Total hip Arthroplasty in early-stage nontraumatic osteonecrosis of the femoral head: a case-control comparative study with a natural course.

Authors:  Zunhan Liu; Xuetao Yang; Yuhan Li; Wei-Nan Zeng; Enze Zhao; Zongke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2021-06-12       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.